Bryan Garnier - MEDINCELL (MED.PA) MEDINCELL: An interesting read-across from recent deal signed by Durect | BUY | EUR10(+43%)

Report

Bryan Garnier

Eric Le Berrigaud

MEDINCELL: An interesting read-across from recent deal signed by Durect | BUY | EUR10(+43%)

MEDINCELL - BUY | EUR10(+43%)
An interesting read-across from recent deal signed by Durect

An inspiring deal between Gilead and Durect
Confirmation of value in LA formulations
HIV: a new area for LA formulations?
Strong rationale for MedinCell to play in HIV

29/07/2019 3 EN

Underlying

MEDINCELL

See profile

Provider

Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

See profile

Analysts

Eric Le Berrigaud

Other Reports on these Companies

Bryan Garnier

MEDINCELL: Interim read-out for mdc-IRMâ€™s phase III delayed into H2 2020 | BUY | EUR9.7 vs. EUR10.3

MEDINCELL - BUY | EUR9.7 vs. EUR10.3 (+30%) Interim read-out for mdc-IRMâ€™s phase III delayed into H2 2020 Unsurprising first-half numbers Status update for mdc-IRM: a difficult-to-interpret new delay What does it mean? We need to adjust our FV

December 4, 2019 December 4, 2019 3 EN

Bryan Garnier

MEDINCELL: Mdc-WWM (contraception) moves forward with the support of the BMGF | BUY | EUR10.3 vs. EUR10 (+48%)

MEDINCELL - BUY | EUR10.3 vs. EUR10 (+48%) Mdc-WWM (contraception) moves forward with the support of the BMGF MedinCell to receive up to USD19m in grants Another validation of the technology MedinCell is holding rights in developed markets FV adjustment to the cash received

November 29, 2019 November 29, 2019 3 EN

Fundamental Research

Feasibility Study Results in December to be a Catalyst for this Junior

EUR 17.22

November 25, 2019 November 25, 2019 14 EN

Avantium: multi-year capacity reservation with Royal Hordijk

This morning, Avantium announced a multi-year capacity reservation agreement (CRA) with Royal Hordijk to supply PEF from its future license network. This deal gives Royal Hordijk preferred access to PEF volumes for making trays and injection-moulded packaging in food, cosmetics and other consumer-g

17h / 4m 17h / 4m 1 EN

Mahaut Arnaud ... (+3)

Mahaut Arnaud
Paul de Froment
Thomas Mordelle

Fastned: EUR34.7m bond issue

Yesterday, Fastned announced it has raised more than EUR34.7m from its second bond issue to retail investors this year, with EUR28.8m contributed in new investments and EUR5.9m rolled from earlier tranches. This brings the total amount of retail bonds raised in 2025 to more than EUR71m (vs EUR82m i

17h / 4m 17h / 4m 1 EN

Clément Genelot

Clément Genelot

Casino: covenant breach still very likely from H2 26; what's next?

We have updated our model, lifting our FY25-27 EBITDA by c.9% and our PT to €0.38, to take into account an improving French grocery market, increasingly driven by an uptick in food inflation. Despite this improvement, we continue to forecast a covenant breach from Q3 26 and believe Mr Kretinsky wil

17h / 46m 17h / 46m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

MEDINCELL: An interesting read-across from recent deal signed by Durect | BUY | EUR10(+43%)

MEDINCELL: Interim read-out for mdc-IRMâ€™s phase III delayed into H2 2020 | BUY | EUR9.7 vs. EUR10.3

MEDINCELL: Mdc-WWM (contraception) moves forward with the support of the BMGF | BUY | EUR10.3 vs. EUR10 (+48%)

Feasibility Study Results in December to be a Catalyst for this Junior

Avantium: multi-year capacity reservation with Royal Hordijk

Fastned: EUR34.7m bond issue

Casino: covenant breach still very likely from H2 26; what's next?

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe